Connecting classroom learning with real-world possibility is how futures are built. 🌍 This week Jamie Heaslip of Stripe shared why partnerships between education and industry at the Stripe Young Scientist & Technology Exhibition matter. We are delighted to be meeting the next generation of innovators all week at the exhibition and introducing them to the work of the Amgen Foundation 🔬🧬. #StripeYSTE2026
About us
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
- Website
-
http://www.amgen.com
External link for Amgen
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Thousand Oaks, CA
- Type
- Public Company
- Founded
- 1980
- Specialties
- Biologics, Human therapeutics, and Development of novel products
Locations
Employees at Amgen
Updates
-
We’re building the next generation of biotechnology leaders—could you be one of them? Amgen interns put all they’ve learned in the classroom into practice. Tackle real-world projects, learn from experienced mentors and play a key role in making a difference for patients. Learn more about our internships: https://bit.ly/44VyIlU
-
-
It’s a new year—and a new chapter to live, win, and thrive. If you’ve been thinking about taking the next step in your career and making an impact for patients worldwide, explore our open roles today: https://bit.ly/3GYzpOX
-
-
Heading into 2026: Amgen bolsters its oncology pipeline. Amgen will acquire UK-based Dark Blue Therapeutics Ltd. adding an investigational small molecule to treat acute myeloid leukemia (AML). “Acute myeloid leukemia remains one of the most difficult cancers to treat, and we see an urgent need for new mechanisms capable of changing the trajectory of this disease,” said Jay Bradner, M.D., EVP of R&D at Amgen. 🔗 Acquisition Details: https://amgen.ly/3Yr57gs
-
-
Making an impact for patients can be tiring work. That’s why it’s important to take time to disconnect, get cozy and celebrate the season. At the end of each year, all U.S. based Amgen employees receive time off to relax, recharge and reconnect with friends and family. This annual winter shutdown is just one of the many work-life balance benefits our employees enjoy! Learn more about our support, here: https://bit.ly/2LM2raD
-
2025 was a year of momentum for Amgen. Check out some highlights and read more here: https://amgen.ly/4j4tjid
-
Amgen is committed to affordability, access and long-term scientific innovation in the U.S. Today, we are announcing action with the U.S. government to lower the cost of medicines for American patients. We are also expanding our direct-to-patient program, AmgenNow™, to include additional Amgen medicines at a discounted price for eligible American patients. 🔗 Read more: https://amgen.ly/4jcCUUe
-
Our New Albany location is hiring, and there are plenty of roles to choose from. Whether you’re just getting started in your career or want to take your skills to biotech—you can make a positive impact for patients worldwide with us. Learn more about joining our Ohio team and how our award-winning support can empower you to accomplish more in your career: https://bit.ly/46tCS5x
-
More than 80% of women over 50 remain undiagnosed and untreated for osteoporosis one year after a fracture. This gap in care underscores the growing urgency for stronger, integrated post-fracture pathways that can help identify and manage postmenopausal osteoporosis sooner. In a recent episode of Becker's Healthcare podcast, Amgen’s Christen Buseman, PhD MPH sat down with Jared Torkelson from Mayo Clinic Health System and Matt Bruns DNP, ONP-C, CCD, MBA from SSM Health Orthopedics to discuss how stronger coordination between orthopedic teams, primary care, and health systems at large can help close the post-fracture care gap. Listen to the full conversation here: https://amgen.ly/3L6WEMc #AmgenSponsored
Closing the Post-Fracture Care Gap